Incorporating Novel Biomarkers in Definitions of Drug-Induced Acute Kidney Injury.
作者信息
Teo Boon Wee, Parikh Chirag R
机构信息
Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Division of Nephrology; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Kidney Int Rep. 2025 Mar 13;10(5):1313-1314. doi: 10.1016/j.ekir.2025.03.013. eCollection 2025 May.
Abstract
摘要
相似文献
1
Incorporating Novel Biomarkers in Definitions of Drug-Induced Acute Kidney Injury.将新型生物标志物纳入药物性急性肾损伤的定义中。
Kidney Int Rep. 2025 Mar 13;10(5):1313-1314. doi: 10.1016/j.ekir.2025.03.013. eCollection 2025 May.
2
Clinical Application of Kidney Biomarkers in Cirrhosis.肝硬化中肾生物标志物的临床应用。
Am J Kidney Dis. 2020 Nov;76(5):710-719. doi: 10.1053/j.ajkd.2020.03.016. Epub 2020 Jul 1.
3
Precision and improving outcomes in acute kidney injury: Personalizing the approach.急性肾损伤的精准性与改善预后：个性化治疗方法
J Crit Care. 2017 Feb;37:244-245. doi: 10.1016/j.jcrc.2016.08.027. Epub 2016 Sep 13.
4
Acute kidney injury: current concepts and new insights.急性肾损伤：当前概念与新见解
J Inj Violence Res. 2016 Jan;8(1):58-62. doi: 10.5249/jivr.v8i1.610.
5
Relationship between acute kidney injury and mortality in poisoning - a systematic review and metanalysis.中毒患者急性肾损伤与死亡率的关系：系统评价和荟萃分析。
Clin Toxicol (Phila). 2021 Sep;59(9):771-779. doi: 10.1080/15563650.2021.1928161. Epub 2021 Jun 3.
6
Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.胱抑素 C 升高定义的急性肾损伤与行心脏手术儿童的生物标志物和临床结局的关联。
JAMA Pediatr. 2015 Jun;169(6):583-91. doi: 10.1001/jamapediatrics.2015.54.
7
Should the novel biomarkers be incorporated in future definitions of acute kidney injury?
Nephrol Dial Transplant. 2020 Aug 1;35(8):1285-1288. doi: 10.1093/ndt/gfz270.
8
Defining Acute Kidney Injury.定义急性肾损伤。
Crit Care Clin. 2021 Apr;37(2):251-266. doi: 10.1016/j.ccc.2020.11.001.
9
Review of the limitations of current biomarkers in acute kidney injury clinical practices.急性肾损伤临床实践中当前生物标志物的局限性综述。
SAGE Open Med. 2024 Feb 5;12:20503121241228446. doi: 10.1177/20503121241228446. eCollection 2024.
10
Linking injury to outcome in acute kidney injury: a matter of sensitivity.将损伤与急性肾损伤的结局联系起来：敏感性问题。
PLoS One. 2013 Apr 23;8(4):e62691. doi: 10.1371/journal.pone.0062691. Print 2013.
本文引用的文献
1
Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers.使用新型生物标志物早期灵敏检测顺铂诱导的肾损伤
Kidney Int Rep. 2025 Feb 5;10(4):1175-1187. doi: 10.1016/j.ekir.2025.01.035. eCollection 2025 Apr.
2
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury.健康个体以及肾毒性和缺血性损伤后尿液中的肾脏损伤生物标志物谱
Clin Pharmacol Ther. 2025 May;117(5):1272-1283. doi: 10.1002/cpt.3531. Epub 2025 Jan 4.
3
Overview of Antibiotic-Induced Nephrotoxicity.抗生素诱导的肾毒性概述
Kidney Int Rep. 2023 Aug 25;8(11):2211-2225. doi: 10.1016/j.ekir.2023.08.031. eCollection 2023 Nov.
4
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.急性疾病质量倡议共识会议关于急性肾损伤生物标志物的建议：共识声明。
JAMA Netw Open. 2020 Oct 1;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.
5
Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.连续定量检测尿液蛋白生物标志物预测药物性急性肾损伤。
Curr Drug Metab. 2019;20(8):656-664. doi: 10.2174/1389200220666190711114504.
6
Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine.急性肾损伤的表型分析：超越血清肌酐。
Semin Nephrol. 2018 Jan;38(1):3-11. doi: 10.1016/j.semnephrol.2017.09.002.
7
Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.临床实践和研究中尿生物标志物与肌酐的标准化——时机与原因
Singapore Med J. 2015 Jan;56(1):7-10. doi: 10.11622/smedj.2015003.
8
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.KDIGO 美国专家组关于 2012 年急性肾损伤临床实践指南的评论。
Am J Kidney Dis. 2013 May;61(5):649-72. doi: 10.1053/j.ajkd.2013.02.349. Epub 2013 Mar 15.
9
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium.肾脏生物标志物资格申报：FDA-EMEA 与预测性安全检测联盟之间的对话。
Nat Biotechnol. 2010 May;28(5):455-62. doi: 10.1038/nbt.1625. Epub 2010 May 10.
Zotero 插件